发明名称 OLIGOMERIC COMPOUND FOR MODULATION OF SURVIVIN EXPRESSION
摘要 <P>PROBLEM TO BE SOLVED: To provide an oligomeric compound modulating expression of survivin by targeted to nucleic acids coding the survivin. <P>SOLUTION: Oligonucleotides against the survivin gene are provided for modulating the expression of survivin. The compositions include oligonucleotides, particularly antisense oligonucleotides, targeted to nucleic acids encoding survivin. Methods of using these compounds for modulation of survivin expression and for the treatment of diseases associated with either overexpression of survivin, expression of mutated survivin or both are provided. Examples of diseases are cancer such as lung, breast, colon, prostate, pancreas, lung, liver, thyroid, kidney, brain, testes, stomach, alimentary tract, intestine, bowel, spinal cord, sinuses, bladder, urinary tract or ovaries cancers. The oligonucleotides may be composed of deoxyribonucleosides or a nucleic acid analogue (for example; locked nucleic acid or the like) or a combination thereof. <P>COPYRIGHT: (C)2010,JPO&INPIT
申请公布号 JP2010178742(A) 申请公布日期 2010.08.19
申请号 JP20100048437 申请日期 2010.03.04
申请人 SANTARIS PHARMA AS;ENZON PHARMACEUTICALS INC 发明人 HANSEN BO;THRUE CHARLOTTE ALBAEK;PETERSEN KAMILLE DUMONG;WESTERGAARD MAJKEN;WISSENBACH MARGIT
分类号 C12N15/113;A61K31/7088;A61K31/712;A61K31/7125;A61K45/00;A61K47/48;A61K48/00;A61P35/00;C07H21/02;C07H21/04;C12N 主分类号 C12N15/113
代理机构 代理人
主权项
地址